ID UKF-NB-6 AC CVCL_M474 DR Wikidata; Q54990372 RX PubMed=17505515; RX PubMed=22170099; RX PubMed=24466371; RX PubMed=27735941; CC Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. DI NCIt; C3270; Neuroblastoma DI ORDO; Orphanet_635; Neuroblastoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) CA Cancer cell line DT Created: 05-11-13; Last updated: 29-06-23; Version: 9 // RX PubMed=17505515; DOI=10.1038/sj.bjc.6603777; PMCID=PMC2359931; RA Blaheta R.A., Michaelis M., Natsheh I., Hasenberg C., Weich E., RA Relja B., Jonas D., Doerr H.-W., Cinatl J. Jr.; RT "Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant RT neuroblastoma tumour cells to endothelium."; RL Br. J. Cancer 96:1699-1706(2007). // RX PubMed=22170099; DOI=10.1038/cddis.2011.129; PMCID=PMC3252738; RA Michaelis M., Rothweiler F., Barth S., Cinatl J., van Rikxoort M., RA Loschmann N., Voges Y., Breitling R., von Deimling A., Rodel F., RA Weber K., Fehse B., Mack E., Stiewe T., Doerr H.-W., Speidel D., RA Cinatl J. Jr.; RT "Adaptation of cancer cells from different entities to the MDM2 RT inhibitor nutlin-3 results in the emergence of p53-mutated RT multi-drug-resistant cancer cells."; RL Cell Death Dis. 2:e243.1-e243.8(2011). // RX PubMed=24466371; DOI=10.1593/tlo.13544; PMCID=PMC3890703; RA Loschmann N., Michaelis M., Rothweiler F., Zehner R., Cinatl J., RA Voges Y., Sharifi M., Riecken K., Meyer J., von Deimling A., RA Fichtner I., Ghafourian T., Westermann F., Cinatl J. Jr.; RT "Testing of SNS-032 in a panel of human neuroblastoma cell lines with RT acquired resistance to a broad range of drugs."; RL Transl. Oncol. 6:685-696(2013). // RX PubMed=27735941; DOI=10.1038/cddis.2016.257; PMCID=PMC5133961; RA Voges Y., Michaelis M., Rothweiler F., Schaller T., Schneider C., RA Politt K., Mernberger M., Nist A., Stiewe T., Wass M.N., Rodel F., RA Cinatl J. Jr.; RT "Effects of YM155 on survivin levels and viability in neuroblastoma RT cells with acquired drug resistance."; RL Cell Death Dis. 7:e2410.1-e2410.11(2016). //